NCT00295893 Combination Chemotherapy With or Without Trastuzumab in Treating Patients With Stage II or Stage III Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT00294931 Irinotecan, Carboplatin, Bevacizumab in the Treatment of Patients With Extensive Stage Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00294762 Erlotinib (Tarceva) as a Single Agent or Intercalated With Combination Chemotherapy in Patients With EGFR Positive NSCLC Status COMPLETED Phase PHASE2
NCT00293475 Methotrexate, Mannitol, Rituximab, and Carboplatin in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma Status UNKNOWN Phase PHASE1/PHASE2
NCT00293358 Combination Chemotherapy and Radiation Therapy in Treating Patients With Germ Cell Tumors in the Brain Status COMPLETED Phase PHASE3
NCT00293332 Docetaxel, Carboplatin, and Bevacizumab in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Can Be Removed By Surgery Status TERMINATED Phase PHASE2
NCT00288041 Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Metastatic Melanoma Status COMPLETED Phase PHASE2
NCT00287989 Erlotinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III, Stage IV, or Recurrent Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00287950 Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Infants With Neuroblastoma Status UNKNOWN Phase NA
NCT00287937 Vorinostat, Paclitaxel, and Carboplatin in Treating Patients With Advanced or Refractory Solid Tumors Status COMPLETED Phase PHASE1
NCT00281905 Combination Chemotherapy With or Without Radiation Therapy in Treating Children With Brain Tumors Status UNKNOWN Phase PHASE2
NCT00281827 Carboplatin, Gemcitabine, and Thalidomide in Patients Undergoing Surgery for Stage II or III Non-Small Cell Lung Cancer Status TERMINATED Phase PHASE2
NCT00281788 Combination Chemotherapy and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer Status COMPLETED Phase PHASE1
NCT00280787 Induction Chemotherapy Using Paclitaxel, Carboplatin, CPT-11 With Pegfilgrastim Status COMPLETED Phase PHASE2
NCT00280735 Ph II Adjuvant Carboplatin/Docetaxel in Curatively Resected Stage I-IIIA NSCLC Status COMPLETED Phase PHASE2
NCT00280150 Combination Chemotherapy, Bev, RT, and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00278148 Erlotinib, Paclitaxel, and Carboplatin Combined With Radiation Therapy for Stage III Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00277069 Phase I-II Study of Carboplatin, Vinorelbine and Capecitabine in Patients With Metastatic Breast Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00276731 Combination Chemotherapy Followed By Surgery With or Without Radiation Therapy in Treating Young Patients With Stage II or Stage III Neuroblastoma Status UNKNOWN Phase PHASE3